Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
228
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Nuvalent Inc - Ordinary Shares - Class A market cap is $9.79B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nuvalent Inc - Ordinary Shares - Class A 52 week high is $123.99 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nuvalent Inc - Ordinary Shares - Class A 52 week low is $71.13 as of November 21, 2026.
Nuvalent Inc - Ordinary Shares - Class A stock price today is $123.96.
Nuvalent Inc - Ordinary Shares - Class A stock price yesterday was $123.94.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Nuvalent Inc - Ordinary Shares - Class A's P/E ratio is -20.46.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Nuvalent Inc - Ordinary Shares - Class A P/B ratio is 8.3264.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Nuvalent Inc - Ordinary Shares - Class A 50-day moving average is $115.12.
Nuvalent Inc - Ordinary Shares - Class A has 228 employees.